NCT04021784View on ClinicalTrials.gov

Limited-efficacy Testing of SDS and NEMOST for Early Onset Neuromuscular Scoliosis

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

March 13, 2023

Study Completion Date

March 13, 2023

Conditions
Neuromuscular ScoliosisDistraction SystemGrowth Friendly System
Interventions
DEVICE

SDS

The patient is implanted with SDS.

DEVICE

NEMOST

The patient is implanted with NEMOST.

Trial Locations (3)

1105AZ

Amsterdam UMC, Amsterdam

Unknown

Erasmus Medical Center, Rotterdam

3584CX

UMC Utrecht, Utrecht

All Listed Sponsors
collaborator

EUROS

INDUSTRY

lead

UMC Utrecht

OTHER

NCT04021784 - Limited-efficacy Testing of SDS and NEMOST for Early Onset Neuromuscular Scoliosis | Biotech Hunter | Biotech Hunter